Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom

Murphy, A., Fenwick, E., Toff, W.D., Neilson, M.P., Berry, C. , Uren, N., Oldroyd, K.G. and Briggs, A.H. (2013) Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. International Journal of Technology Assessment in Health Care, 29(01), pp. 12-19. (doi:10.1017/S0266462312000670)

Full text not currently available from Enlighten.

Abstract

Aortic stenosis (AS) is caused by age-related calcific degeneration of the aortic valve (1). Initially, cases are asymptomatic but, from the point that symptoms first develop, there is rapid progression and if left untreated survival estimates are low (2–3 years) (1). Therefore, managing AS effectively and efficiently is a priority for health systems with increasing healthcare costs and longer life expectancy.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Berry, Professor Colin and Briggs, Professor Andrew and Oldroyd, Dr Keith and Fenwick, Professor Elisabeth and Neilson, Dr Matthew
Authors: Murphy, A., Fenwick, E., Toff, W.D., Neilson, M.P., Berry, C., Uren, N., Oldroyd, K.G., and Briggs, A.H.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
Journal Name:International Journal of Technology Assessment in Health Care
ISSN:0266-4623
ISSN (Online):1471-6348
Published Online:09 January 2013

University Staff: Request a correction | Enlighten Editors: Update this record